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        Introduction 
  In response to genotoxic stress, eukaryotic cells elicit DNA 
damage checkpoint responses, which delay cell cycle progres-
sion and stimulate DNA repair to restore genomic integrity 
(  Zhou and Elledge, 2000  ;   Bartek and Lukas, 2007  ). DNA dam-
age triggers rapid degradation of the Cdk-activating phospha-
tase, Cdc25A, by the SCF 
   TrCP   ubiquitin ligase to arrest the cell 
cycle in a reversible fashion (  Mailand et al., 2000  ;   Busino et al., 
2003 ). This process requires priming phosphorylation of Cdc25A 
by the checkpoint kinase Chk1, which is itself activated by 
phosphorylation by the upstream kinase ataxia telangiectasia 
and Rad3-related (ATR). Effi  cient ATR-mediated phosphoryla-
tion of Chk1 occurs only in the presence of the checkpoint me-
diator Claspin, a key determinant for Chk1 activation (  Kumagai 
and Dunphy, 2000  ). Upon entry into mitosis and during recov-
ery from DNA damage  –  induced cell cycle arrest, Claspin under-
goes proteasomal degradation, and such control of Claspin 
levels plays a pivotal role in restraining Chk1 activity under 
these conditions (  Mailand et al., 2006  ;   Mamely et al., 2006  ; 
  Peschiaroli et al., 2006  ). Like in the case of Cdc25A, the de-
struction of Claspin is also mediated by SCF 
   TrCP ;  hence,  this 
complex plays a key role in initiating as well as terminating 
DNA damage checkpoints. These fi  ndings have helped to estab-
lish regulated ubiquitylation as a major signaling mechanism in 
the DNA damage response. 
  The removal of ubiquitin conjugates from target proteins 
by deubiquitylating enzymes (DUBs) has emerged as an impor-
tant regulatory mechanism in a range of cellular processes. An 
estimated 79 functional DUBs are encoded by the human ge-
nome, but as yet, only few of these have been assigned func-
tions or substrates (  Nijman et al., 2005b  ). Available evidence 
suggests that the specifi  city and regulatory potential of DUBs 
may be comparable to that of E3 ubiquitin ligases, underscoring 
the dynamic and reversible nature of protein ubiquitylation. 
Several DUBs have been found to function in the DNA damage 
response, including ubiquitin-specifi  c protease 1 (USP1), USP7, 
and USP28 (  Nijman et al., 2005a  ;   Huang et al., 2006  ;   Zhang 
et al., 2006  ). For instance, USP7 (also known as HAUSP) is a 
DUB for Mdm2 (  Li et al., 2004  ), a ubiquitin ligase for p53, and 
is thus an important factor in the control of p53 abundance dur-
ing the cell cycle. 
C
laspin is an adaptor protein that facilitates the 
ataxia telangiectasia and Rad3-related (ATR)-
mediated phosphorylation and activation of 
Chk1, a key effector kinase in the DNA damage re-
sponse. Efﬁ  cient termination of Chk1 signaling in mitosis 
and during checkpoint recovery requires SCF 
    TrCP  -
  dependent destruction of Claspin. Here, we identify the 
deubiquitylating enzyme ubiquitin-speciﬁ  c  protease  7 
(USP7) as a novel reg  ulator of Claspin stability. Claspin 
and USP7 interact in vivo, and USP7 is required to 
maintain steady-state levels of Claspin. Furthermore, 
USP7-mediated deubiquitylation markedly prolongs the 
half-life of Claspin, which in turn increases the magnitude 
and duration of Chk1 phosphorylation in response 
to genotoxic stress. Finally, we ﬁ  nd that in addition to 
the M phase  –  speciﬁ  c, SCF 
    TrCP  -mediated degradation, 
Claspin is destabilized by the anaphase-promoting 
complex (APC) and thus remains unstable in G1. Impor-
tantly, we demonstrate that USP7 speciﬁ  cally opposes 
the SCF 
    TrCP  - but not APC 
Cdh1  -mediated degradation of 
Claspin. Thus, Claspin turnover is controlled by multiple 
ubiquitylation and deubiquitylation activities, which to-
gether provide a ﬂ  exible means to regulate the ATR  –
  Chk1 pathway.
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also required for Chk1 activation in response to genotoxic 
insults, was not affected by knockdown of USP7 or other DUBs 
(  Fig. 1 A  ). A mixture of three independent oligonucleotides 
was used to effi  ciently knock down USP7 expression, and the 
effect of USP7 depletion on Claspin levels could be reproduced 
with individual siRNAs to USP7 (Fig. S1 A, available at http://
www.jcb.org/cgi/content/full/jcb.200807137/DC1). To clarify 
whether Claspin is a direct target of USP7, we tested whether 
the two proteins copurify in immunoprecipitation (IP) experi-
ments. Indeed, USP7 and Claspin readily interacted under con-
ditions where both proteins were overexpressed (  Fig. 1 B  ), and 
we could also detect association between the endogenous pro-
teins (  Fig. 1 C  ). In contrast, we did not observe binding of 
Claspin to several other DUBs (unpublished data), underscor-
ing the specifi  city of the Claspin  –  USP7 interaction. To further 
probe the relationship between USP7 and Claspin, we assessed 
the Claspin-binding capability of wild-type (WT) or catalyti-
cally inactive (CI) USP7. In such experiments, USP7 CI inter-
acted more strongly with endogenous Claspin than did WT 
USP7 (  Fig. 1 D  ), which is consistent with a substrate-trapping 
mechanism in which an inability of inactive USP7 to deubiqui-
tylate Claspin would manifest as a prolonged binding and thus 
a tighter interaction. These observations suggest that Claspin is 
a novel substrate for USP7. 
  Interestingly, depletion of USP7 also led to a signifi  cant 
down-regulation of total Chk1 levels (  Fig. 1 A  ), but we failed to 
produce credible evidence that Chk1 is a direct target for USP7. 
In particular, whereas Claspin avidly interacted with USP7, the 
amount of Chk1 coimmunoprecipitated with ectopic USP7 did not 
signifi  cantly exceed that observed in the control cells (  Fig. 1 D  ). In 
addition, knockdown of Claspin or Chk1 negatively affected the 
expression level of the other protein (Fig. S1 C), which suggests 
that Claspin and Chk1 may promote the stability of each other, 
in agreement with previous fi  ndings (  Yang et al., 2008  ). Thus, it 
seems likely that the effects on Chk1 levels observed in response 
to up- or down-regulation of USP7 may be indirectly mediated 
through its impact on Claspin. 
  USP7 deubiquitylates and stabilizes Claspin 
  To corroborate the emerging link between USP7 and Claspin, 
we generated cell lines capable of conditionally expressing WT 
or CI mutant forms of Myc-tagged USP7. Induction of USP7 in 
these cell lines resulted in homogenous nuclear expression of 
the transgenes in virtually all cells, but had little impact on cell 
cycle distribution (Fig. S2, available at http://www.jcb.org/cgi/
content/full/jcb.200807137/DC1; and not depicted). Using these 
cell lines, we asked whether overexpression of USP7 would 
have a stabilizing effect on endogenous Claspin. Expression of 
USP7 WT clearly resulted in an elevation of Claspin levels, 
whereas no such effect could be seen in cells induced to express 
USP7 CI (  Fig. 2 A  ). Only a slight increase in Chk1 levels was 
evident under these conditions, which further supports the no-
tion that Claspin rather than Chk1 is a target of USP7. As a con-
trol for the functionality of ectopic USP7 in the cell lines, we 
analyzed its impact on Mdm2, a known target for USP7. Indeed, 
Mdm2 abundance was strongly elevated in a manner dependent 
on the catalytic activity of USP7 but independent of cell cycle 
  In this report, we show that the control of Claspin stability 
is more complex than previously anticipated, involving both 
ubiquitylation and deubiquitylation to allow cells to fi  nely 
gauge the levels of Claspin. We identify USP7 as a major DUB 
for Claspin, with a consequent impact on Chk1 phosphorylation 
and checkpoint recovery. We also demonstrate that Claspin is 
degraded by the anaphase-promoting complex (APC) in the G1 
phase, and that USP7 specifi  cally counteracts SCF 
   TRCP -  but  not 
APC 
Cdh1  -mediated ubiquitylation of Claspin. 
  Results and discussion 
  Claspin interacts with USP7 
  To explore the dynamic control of Claspin stability, we investi-
gated whether Claspin is regulated by deubiquitylation activities. 
Focusing on a selected set of DUBs, which have previously been 
implicated in the DNA damage response, we monitored the re-
sponse of Claspin levels to siRNA-mediated down-regulation of 
these DUBs. Consistent with published results (  Zhang et al., 
2006  ), we observed a partial reduction in Claspin level after 
knocking down USP28 (  Fig. 1 A  ). Strikingly, however, we con-
sistently detected a much more prominent decrease of Claspin 
expression after depletion of USP7, which suggests that USP7 
might protect Claspin from ubiquitylation-dependent degrada-
tion (  Fig. 1 A  ). However, the abundance of TopBP1, which is 
  Figure 1.       Claspin interacts with USP7.   (A) U2OS cells were transfected 
with indicated siRNAs for 72 h and analyzed by IB with the indicated 
antibodies. The functionality of the USP1 siRNA has been demonstrated 
previously (  Huang et al., 2006  ). (B) Lysates of 293T cells transfected with 
indicated plasmids for 24 h were subjected to Myc IP followed by IB. (C) Ly-
sates of 293T cells were subjected to IP with USP7 antibody or preimmune 
rabbit serum (IgG) followed by IB. (D) 293T cells were transfected with WT 
or CI forms of Myc-USP7, and processed as in B. The extra band in the 
USP7 CI lane corresponds to ubiquitylated USP7 (unpublished data).     15 DEUBIQUITYLATION OF CLASPIN BY USP7   • Faustrup et al. 
G1 (  Mailand et al., 2006  ). Degradation of Claspin at the onset 
of mitosis is driven by its ubiquitylation by SCF 
   TrCP ,  and  we 
therefore asked whether overexpression of USP7 could counter-
act this process. To this end, we assessed the impact of ectopic 
USP7 on the levels of Claspin in mitotic cells. In uninduced 
cells, Claspin was indeed expressed at much lower levels in 
mitotic cells than in exponentially growing cells (  Fig. 2 D  ). 
However, as would be expected if USP7 was able to reverse 
SCF 
   TrCP -mediated ubiquitylation of Claspin, induction of USP7 
WT fully restored Claspin levels to those seen in asynchronous 
cells (  Fig. 2 D  ). Again, this propensity of USP7 was dependent 
on the catalytic activity of USP7, as the abundance of Claspin 
remained low in mitotic cells expressing USP7 CI (  Fig. 2 D  ). 
Because extracts from mitotic cells readily support ubiquity-
lation of Claspin in a     TrCP-dependent fashion (  Mailand et al., 
2006  ), we used such an approach to test whether USP7 directly 
stage (  Fig. 2 A   and Fig. S2 C). To clarify further whether Claspin 
is stabilized by USP7-dependent deubiquitylation, we assessed 
the half-life of Claspin in cells expressing ectopic USP7 by add-
ing cycloheximide to block protein synthesis. Overexpression 
of USP7 WT brought about a robust, three- to fourfold increase 
in the stability of Claspin as compared with uninduced cells, in 
which the half-life of Claspin was very short (    1 h,   Fig. 2 B  ). 
In contrast, little if any effect on Claspin stability was evident in 
cells expressing USP7 CI (  Fig. 2 C  ), which supports the idea 
that Claspin is deubiquitylated by USP7. 
  USP7 reverses SCF 
    TrCP  -dependent 
ubiquitylation of Claspin 
  We have previously shown that the levels of Claspin oscillate in 
a cell cycle  –  dependent manner, being high in S and G2 phases 
and declining sharply upon entry into mitosis and throughout 
  Figure 2.       USP7 deubiquitylates and sta-
bilizes Claspin.   (A) U2OS/Myc-USP7 cell 
lines were induced with doxycycline (DOX), 
harvested at the indicated times, and pro-
cessed for IB with the indicated antibodies. 
(B) U2OS/Myc-USP7 WT cells were induced 
or not induced with DOX for 30 h, after which 
cycloheximide (CHX) was added to the cultures 
for the indicated times. The half-life of Claspin 
was estimated by IB of total cell extracts. 
(C) U2OS/Myc-USP7 CI cells were treated as 
in B. (D) U2OS/Myc-USP7 WT or CI cells were 
induced or not induced for 18 h with DOX, 
and left untreated (Exp) or incubated with no-
codazole for an additional 12 h to synchro-
nize cells in mitosis (M). The cell extracts were 
then analyzed by IB. Mobility-shifted Wee1 
served as a marker for mitotically synchro-
nized cells. (E) [ 
35  S]-labeled Claspin (amino 
acids 1  –  380) was incubated in ubiquitylation 
reaction mix, then supplemented with extracts 
of exponentially growing or mitotic U2OS cells 
and in vitro  –  translated     TrCP1. Where indi-
cated, bacterially puriﬁ  ed GST-USP7 WT was 
added to the reaction. Claspin ubiquitylation 
was visualized by autoradiography. Numbers 
to the right of the gel blots indicate molecular 
mass standards in kD. (F) U2OS/Myc-USP7 
cell lines were transfected with indicated con-
structs for 24 h, and lysates were processed 
for IP with FLAG antibody and IB.     JCB • VOLUME 184 • NUMBER 1 • 2009  16
fact that priming phosphorylation of Claspin by the Plk1 ki-
nase is required for its SCF 
   TrCP -mediated destruction ( Mailand 
et al., 2006  ;   Mamely et al., 2006  ;   Peschiaroli et al., 2006  ); the 
absence of Plk1 in G1, because of its destruction by APC 
Cdh1  
(  Peters, 2006  ), thus necessitates a Plk1-independent mecha-
nism for the G1-specifi  c degradation of Claspin. 
  As mentioned previously, the APC 
Cdh1 -mediated  degrada-
tion of Claspin appeared insensitive to USP7 activity (  Fig. 3 A  ), 
and to confi  rm this, we tested the ability of APC 
Cdh1   to degrade 
Claspin in the presence of elevated levels of USP7. Unlike inacti-
vation of APC 
Cdh1 , expression of ectopic USP7 WT did not restore 
Claspin expression in G1 (  Fig. 3 E  ), which indicates that the sta-
bilization of Claspin observed in these cells (  Fig. 2, A and B  ) hap-
pens outside G1 phase. In addition, overexpressed USP7 failed to 
counteract Claspin degradation mediated by activated APC 
Cdh1  
(  Fig. 3 F  ). We conclude from these experiments that USP7 selec-
tively opposes the SCF 
   TrCP  - but not APC 
Cdh1 -dependent  degrada-
tion of Claspin, which suggests that the molecular nature of 
ubiquitin chains attached to Claspin by APC 
Cdh1   and SCF 
   TrCP  
differ in terms of their susceptibility or accessibility to USP7-
mediated deubiquitylation. 
  USP7 controls the timing of checkpoint-
induced Chk1 phosphorylation through 
regulation of Claspin stability 
  The role of USP7 in maintaining steady-state levels of Claspin 
suggested that modulation of USP7 activity might affect Chk1 
regulation during checkpoint responses. To test this, we fi  rst 
assessed the ability of USP7-depleted cells to activate Chk1. 
Consistent with the quantitative loss of Claspin in such cells, 
knockdown of USP7 strongly impaired UV-dependent activa-
tion of Chk1, as judged from its phosphorylation on Ser317 
(  Fig. 4 A  ). As with Claspin levels, this effect was specifi  c to 
USP7, as neither depletion of USP1 or USP28 signifi  cantly 
compromised UV-induced Chk1 phosphorylation (  Fig. 4 A  ). 
Hence, these data suggest that USP7 is required for Chk1 acti-
vation in response to DNA damage. 
  Destruction of Claspin by SCF 
   TrCP   promotes the timely in-
activation of Chk1 during recovery from DNA damage  –  induced 
cell cycle arrest (  Mailand et al., 2006  ;   Mamely et al., 2006  ;   
Peschiaroli et al., 2006  ), and because USP7 protects Claspin 
from     TrCP-dependent degradation, we reasoned that the ac-
tivity of USP7 might be a contributing factor in timing the du-
ration of Chk1 phosphorylation during checkpoint responses. 
To this end, we analyzed the kinetics of Chk1 dephosphoryla-
tion, and thus checkpoint termination, in USP7 cell lines re-
leased from a replication block induced by hydroxyurea (HU). 
We consistently observed a strong delay in the ability of USP7 
WT-induced cells to degrade Claspin and inactivate Chk1 after 
release from the HU-induced arrest, relative to uninduced cells 
(  Fig. 4 B  ). This was accompanied by a slower rate of cell cycle 
progression upon HU removal, which might at least partially 
refl  ect the delayed kinetics of Claspin degradation in these 
cells (Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200807137/DC1). The overall levels of Chk1 remained 
somewhat higher in cells induced to express USP7 WT, which 
is in agreement with the previously observed correlation 
deubiquitylates Claspin in vitro. As shown in   Fig. 2 E  , the 
polyubiquitylation of Claspin observed in mitotic cells was in-
hibited when purifi  ed GST-tagged USP7 WT was added to the 
reaction. In addition, induction of USP7 WT but not USP CI 
quantitatively suppressed the appearance of polyubiquitylated 
Claspin species in cells (  Fig. 2 F  ), which indicates that USP7 
is a major Claspin-directed DUB. Together, these results dem-
onstrate that USP7 stabilizes Claspin by directly opposing its 
    TrCP-mediated ubiquitylation. Hence, the balance of ubiqui-
tylation and deubiquitylation activities allow for subtle control 
of steady-state levels of Claspin. 
  Claspin is degraded by the APC in G1 
  Although elevated levels of USP7 WT were able to maintain 
Claspin expression during mitosis, we noted that it was still 
degraded upon reentry into G1 phase (  Fig. 3 A  ). This sug-
gested that once in G1, Claspin becomes susceptible to degra-
dation by a   TrCP-independent mechanism refractory to USP7 
activity. We reasoned that under these conditions, the destruc-
tion of Claspin might instead be driven by the APC, which 
promotes the degradation of numerous regulatory proteins in 
late mitosis and G1 (  Peters, 2006  ). To test this possibility, we 
coexpressed Claspin with Cdh1, the substrate-specifi  c activa-
tor of the APC in G1, using the fi  nding that elevated levels of 
Cdh1 are suffi  cient to trigger APC activation irrespective of 
cell cycle stage (  Sorensen et al., 2000  ). In the presence of high 
levels of Cdh1, the expression of Claspin was strongly sup-
pressed (  Fig. 3 B  ), which suggests that Claspin is indeed a 
target for APC-mediated degradation. To further probe this pro-
teolytic mechanism, we used an immunofl  uorescence-based ap-
proach to monitor Claspin abundance in G1 cells. Although 
Claspin was detectable only at background levels in G1 phase 
(Cyclin B1  –  negative) nuclei, treatment with a proteasome in-
hibitor (MG132) was suffi  cient to restore Claspin expression 
to levels comparable with S and G2 phase cells (  Fig. 3 C  ), 
demonstrating that Claspin is actively degraded by the protea-
some in G1. Next, we subjected cells to siRNA-mediated de-
pletion of     TrCP or Cdh1 to test whether the degradation of 
Claspin in G1 cells was predominantly mediated by SCF 
   TrCP  
or APC 
Cdh1  . Although Claspin did not accumulate in G1 cells 
in response to knockdown of     TrCP, its expression in G1 was 
effi  ciently restored upon depletion of Cdh1 (  Fig. 3 C  ), indicat-
ing that the degradation of Claspin in G1 phase is mediated by 
APC 
Cdh1  but not SCF 
   TrCP . In contrast, we had previously shown 
that the APC was unable to promote the degradation of Claspin 
in early mitosis (  Mailand et al., 2006  ). Thus, two distinct path-
ways operate to limit Claspin abundance during the cell cycle, 
in a manner much like Cdc25A, whose destruction is also con-
trolled by both SCF 
   TrCP   and  APC 
Cdh1   ( Donzelli  et  al.,  2002 ). 
We speculate that the APC-mediated degradation of Claspin in 
G1 is an important means of suppressing inappropriate Chk1 
activation during this window of the cell cycle. Indeed, cells 
expressing elevated levels of Cdh1 were markedly impaired in 
their ability to activate Chk1 in response to UV, whereas the 
phosphorylation of other ATR targets remained virtually nor-
mal, as exemplifi  ed by p53 (  Fig. 3 D  ). The choice of APC as 
the machinery for Claspin ubiquitylation in G1 may refl  ect the 17 DEUBIQUITYLATION OF CLASPIN BY USP7   • Faustrup et al. 
  Figure 3.       Degradation of Claspin by APC 
Cdh1   in G1 is not opposed by USP7.   (A) U2OS/Myc-USP7 WT cells were induced or not induced with DOX for 
18 h, and left untreated or synchronized in mitosis by nocodazole treatment for an additional 12 h. Mitotic cells were washed, plated in fresh medium, 
and collected at the indicated times after release. Lysates of these and asynchronous control cells (    ) were analyzed by IB. (B) U2OS/Myc-Cdh1 cells were 
induced by removal of tetracycline (Tet) for the indicated times and processed for IB. (C) U2OS cells were treated with MG132 for 4 h or transfected with 
    TrCP or Cdh1 siRNAs for 48 h. The cells were then ﬁ  xed and immunostained with indicated antibodies. DNA was visualized by counterstaining with 
ToPro3. Arrows indicate G1 cells. Bars, 10   μ  m. (D) U2OS/Myc-Cdh1 cells were induced or not induced by tetracycline withdrawal for 48 h, exposed to 
UV (20 J/m 
2  ), and harvested 1 h later. Total cell extracts were processed for IB. (E) U2OS/Myc-USP7 WT cells were induced or not induced with DOX for 
48 h, and processed for immunoﬂ  uorescence as in C. Arrows indicate G1 cells. Bars, 10   μ  m. (F) U2OS cells were transfected with the indicated plasmids 
for 24 h and processed for IB.     JCB • VOLUME 184 • NUMBER 1 • 2009  18
tion of Chk1 but not other targets (  Liu et al., 2006  ). Most impor-
tantly, we identifi  ed USP7 as a DUB opposing    TrCP-mediated 
ubiquitylation of Claspin, thus broadening the scope of USP7 
functions in the maintenance of genomic integrity. By protect-
ing Claspin from degradation, USP7 may directly impact the 
initiation as well as termination of Chk1-mediated signaling re-
sponses, and hence it will be important to address if and how the 
Claspin-directed activity of USP7 is itself regulated during 
checkpoint responses. A recent study also identifi  ed Claspin as 
a novel APC target, and the DUB USP28 was found to oppose 
its APC-mediated ubiquitylation (  Bassermann et al., 2008  ). 
Hence, two distinct DUBs may be used to counteract Claspin 
ubiquitylation mediated by SCF 
   TrCP   or  APC 
Cdh1  , further high-
lighting the importance of tightly controlling its steady-state 
expression levels during the cell cycle. 
  Materials and methods 
  Plasmids and RNA interference 
  Plasmids expressing WT and CI (C223S) Myc-tagged USP7 (pcDNA3-
Myc-USP7) were gifts from R. Everett (MRC Virology Unit, University of 
Glasgow, Scotland, UK). The inserts were inserted into pcDNA4/TO (Invit-
rogen), allowing for doxycycline-inducible expression of Myc-USP7 WT 
and CI, and into pGEX-20T (GE Healthcare) for bacterial expression of 
GST-USP7 fusion proteins. Other plasmids used in this study included pIRES-
FLAG-Claspin, pCMV2-FLAG-Claspin (amino acids 1  –  448), pX-Myc-Claspin 
(amino acids 1  –  380), pX-Myc-Cdh1, and pX-Myc-    TrCP1, all of which 
have been described previously (  Mailand et al., 2006  ;   Sorensen et al., 
2000  ). Plasmid transfections were performed using FuGene6 (Roche). 
between Chk1 and Claspin levels. Consistent with the inability 
of USP7 CI to stabilize Claspin, cells expressing this mutant 
did not display any checkpoint recovery delay (  Fig. 4 C  ). 
Hence, increased activity of USP7 interferes with the cellular 
ability to timely degrade Claspin and inactivate Chk1 upon 
checkpoint termination. 
  In addition to its role during checkpoint recovery,    TrCP-
dependent degradation of Claspin helps prevent inappropriate 
activation of Chk1 during mitosis (  Mailand et al., 2006  ;   Mamely 
et al., 2006  ). Consequently, mitotic cells depleted for    TrCP 
display partial Chk1 phosphorylation after exposure to geno-
toxic agents. Because USP7 stabilized Claspin in mitosis, we 
tested if mitotic cells overexpressing USP7 WT would allow 
Chk1 activation. Indeed, like     TrCP depletion, elevated levels 
of USP7 WT partially enabled phosphorylation of Chk1 upon 
exposure of mitotic cells to the DNA-damaging agent etoposide 
(  Fig. 4 D  ). These observations suggest that the ubiquitylation 
and deubiquitylation activities toward Claspin must be tightly 
coordinated to enforce Claspin degradation and thus Chk1 in-
activation in mitosis. 
  Collectively, our results uncover a dynamic and complex 
mode of controlling Claspin stability during the cell cycle and 
upon checkpoint-inducing stimuli involving both ubiquitylation 
and deubiquitylation activities. These fi  ndings highlight the 
tuning of Claspin availability as a key regulatory event in path-
ways that govern Chk1 activation, and likely refl  ect the fact that 
Claspin is specifi  cally required for ATR-mediated phosphoryla-
  Figure 4.       USP7 controls the timing of Chk1 
phosphorylation through regulation of Claspin 
stability.   (A) U2OS cells were transfected with 
indicated siRNAs for 72 h, then subsequently 
treated with UV (20 J/m 
2  ) and harvested 
1 h later. Cells were then processed for IB. 
(B) U2OS/Myc-USP7 WT cells were induced 
or not induced with DOX for 12 h, and treated 
with HU for an additional 24 h. Cells were 
then released from the HU block, harvested 
at the indicated times, and processed for IB. 
(C) U2OS/Myc-USP7 CI cells were treated 
as in B. (D) U2OS/Myc-USP7 WT cells were 
induced or not induced with DOX for 24 h, 
and left untreated or synchronized in mitosis 
with nocodazole for an additional 12 h. Cells 
were then treated with etoposide for 2 h where 
indicated, and processed for IB.     19 DEUBIQUITYLATION OF CLASPIN BY USP7   • Faustrup et al. 
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A mixture of three different siRNAs were used to efﬁ  ciently knock down 
USP7, as described previously (  Canning et al., 2004  ). Other siRNAs used 
in this study included USP1 (5    -GGCAAUACUUGCUAUCUUA-3    ;   Nijman 
et al., 2005a  ) and USP28 (5    -CUGCAUUCACCUUAUCAUU-3    ). siRNA to 
Cdh1 and     TrCP have been described previously (  Mailand and Difﬂ  ey, 
2005  ;   Mailand et al., 2006  ). All siRNA duplexes (purchased from Thermo 
Fischer Scientiﬁ  c) were transfected at a ﬁ  nal concentration of 100 nM using 
Lipofectamine RNAiMAX (Invitrogen). 
  Cell culture 
  Human U2OS osteosarcoma cells and HEK293T embryonic kidney cells 
were cultured in DME containing 10% fetal bovine serum. U2OS derivative 
cell lines expressing Myc-tagged USP7 WT or CI in a doxycycline-inducible 
fashion from pcDNA4/TO-Myc-USP7 vectors were generated and main-
tained as described previously (  Mailand et al., 2007  ). The U2OS/Myc-
Cdh1 cell line has been described previously (  Sorensen et al., 2000  ). Cells 
were synchronized in mitosis by shaking off rounded cells after treatment 
with 40 ng/ml nocodazole (Sigma-Aldrich) for 12 h. Other drugs used in 
this study included: 1   μ  g/ml doxycycline (EMD), 2   μ  g/ml tetracycline (EMD), 
2 mM HU (Sigma-Aldrich), 25   μ  g/ml cycloheximide (Sigma-Aldrich), and 
etoposide (50   μ  M for exponential and 100   μ  M for mitotic cells; EMD). 
  Immunochemical methods and microscopy 
  Immunoblotting (IB), IP, and immunoﬂ  uorescence were performed as de-
scribed previously (  Mailand et al., 2006  ). Antibodies used in this study in-
cluded mouse monoclonals to Strep-tag (IBA BioTAGnology) and Mdm2 
(sc-965; Santa Cruz Biotechnology, Inc.); rabbit polyclonals to USP7 
(BL851; Bethyl Laboratories, Inc.), Claspin (BL-73 [Bethyl Laboratories, Inc.] 
and Ab3720 [Abcam], used for IB and immunoﬂ  uorescence, respectively), 
Wee1 (sc-325; Santa Cruz Biotechnology, Inc.), and USP28 (a gift 
from S.J. Elledge, Harvard Medical School, Boston, MA). Antibodies to 
FLAG, Myc, HA, cyclin B1, Chk1, Cdk7, Chk1 S317, SMC1, TopBP1, 
and MCM6 have been described previously (  Mailand et al., 2006  ). Acqui-
sition of confocal images was done essentially as described previously 
(  Bekker-Jensen et al., 2006  ), using a confocal microscope (LSM510; Carl 
Zeiss, Inc.) ﬁ  tted with a Plan-Neoﬂ  uar 40  ×   NA 1.3 oil immersion objective 
lens (Carl Zeiss, Inc.). For dual-color imaging, secondary antibodies cou-
pled to Alexa Fluor dyes with excitation wavelengths of 488 and 568 nm 
were used. Image acquisition and basic image processing were performed 
with LSM software (Carl Zeiss, Inc.). 
  In vitro deubiquitylation assay 
  Claspin was ubiquitylated in vitro essentially as described previously 
(  Mailand et al., 2006  ). In brief, in vitro  –  translated [ 
35  S]Claspin (amino 
acids 1  –  380) was incubated with ubiquitylation reaction mix (40 mM 
Tris-HCl, pH 7.5, 5 mM MgCl  2  , 1 mM DTT, 10% glycerol, 1 mg/ml ubiqui-
tin, 10 mM phosphocreatine, 100   μ  g/ml creatine phosphokinase, 0.5 mM 
ATP, 5   μ  M MG132 [all from Sigma-Aldrich], 5   μ  M human E1, and 2   μ  M 
hUbcH5C [both from Boston Biochem]), then supplemented with 30   μ  g of 
extract from exponentially growing or mitotic U2OS cells (  Mailand et al., 
2006  ) and unlabeled in vitro  –  translated     TrCP1. To assess the deubiquity-
lation activity of USP7 toward Claspin, 1   μ  g of GST-USP7 WT puriﬁ  ed from 
  Escherichia coli   was included in the reaction. Reactions were incubated at 
30  °  C for 1 h, stopped by addition of Laemmli sample buffer, resolved by 
SDS-PAGE, and visualized by autoradiography. 
  Online supplemental material 
  Fig. S1 shows speciﬁ   city and effects of USP7, Claspin, and Chk1 siR-
NAs. Fig. S2 shows characterization of the U2OS/Myc-USP7 inducible 
cell lines. Fig. S3 shows cell cycle proﬁ  les of cells in the experiment in 
  Fig. 4 B   at representative time points, determined by ﬂ  ow  cytometric 
analysis. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200807137/DC1. 
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